Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released May 2, 2023, after the close
10-Q filed May 2, 2023, 32 days after period end · 0001558370-23-007653
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $26.07M | $16.74M | $81.02M | $55.76M |
| Net Income | -$13.54M | -$27.45M | $39.50M | $21.24M |
| EPS Diluted |
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
| -$0.08 |
| -$0.16 |
| $0.22 |
| $0.13 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
